Prelude Capital Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,689
| Closed | -$40.4K | – | 1424 |
|
|
2024
Q3 | $40.4K | Sell |
11,689
-18,300
| -61% | -$63.3K | ﹤0.01% | 1116 |
|
|
2024
Q2 | $87.9K | Buy |
29,989
+19,131
| +176% | +$56.1K | 0.01% | 1018 |
|
|
2024
Q1 | $61.3K | Sell |
10,858
-42,677
| -80% | -$241K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $230K | Buy |
53,535
+34,600
| +183% | +$148K | 0.02% | 759 |
|
|
2023
Q3 | $65.7K | Sell |
18,935
-11,237
| -37% | -$39K | ﹤0.01% | 883 |
|
|
2023
Q2 | $140K | Sell |
30,172
-616
| -2% | -$2.86K | 0.01% | 777 |
|
|
2023
Q1 | $142K | Buy |
30,788
+11,531
| +60% | +$53.3K | 0.01% | 820 |
|
|
2022
Q4 | $156K | Buy |
+19,257
| New | +$156K | 0.01% | 875 |
|
|
2020
Q4 | – | Sell |
-700
| Closed | -$7K | – | 1487 |
|
|
2020
Q3 | $7K | Buy |
700
+300
| +75% | +$3K | ﹤0.01% | 1142 |
|
|
2020
Q2 | $3K | Buy |
400
+100
| +33% | +$750 | ﹤0.01% | 1210 |
|
|
2020
Q1 | $3K | Hold |
300
| – | – | ﹤0.01% | 853 |
|
|
2019
Q4 | $3K | Sell |
300
-1,012
| -77% | -$10.1K | ﹤0.01% | 1328 |
|
|
2019
Q3 | $12K | Buy |
1,312
+402
| +44% | +$3.68K | ﹤0.01% | 1000 |
|
|
2019
Q2 | $10K | Buy |
+910
| New | +$10K | ﹤0.01% | 1016 |
|